Remove Science Remove Small Molecule Remove Synthetic Chemistry
article thumbnail

Part 2 Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis - Recap

The Strateos Blog: Drug Discovery

On September 15th, Strateos hosted Part 2 of its Chemistry Webinar Series: Remote Access Robotic Controlled Compound Synthesis. It’s really a shift towards industrializing how we do science.” Ben Miles, Ph.D., Ben Miles, Ph.D.,

article thumbnail

Global advances in synthetic biology

Drug Discovery World

The company is developing a pan-European biotech studio network covering areas where synthetic biology can create disruptive solutions and high market value products. eureKARE’s synthetic biology studios will focus on biomedical applications – among others – in different European innovation hotspots. References .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Following our pole star to a transformative collaboration

Dark Matter Blog

That’s how we’ll get the greatest leverage from our science and turn it into as many medicines as possible. Our Chinese CROs are back online and doing synthetic chemistry at a pre-pandemic pace. Our relationship with Roche gives us the ability to focus on our science and delivering the first rSMs to patients. We’re lucky.

RNA 52
article thumbnail

AWS helps Pfizer accelerate drug development and clinical manufacturing

The Pharma Data

Working closely with AWS experts in machine learning and analytics, we aim to provide our scientists and researchers with the insights they need to help deliver medical breakthroughs that change patients’ lives,” said Andrew McKillop, Vice President of Pharmaceutical Sciences, Worldwide Research, Development, and Medical at Pfizer.

article thumbnail

Highlights from SLAS 2022 Conference - Event Recap

The Strateos Blog: Drug Discovery

The focus of this year’s SLAS 2022 was to accelerate life sciences research through the adoption and integration of transformative lab automation technologies. The consensus among the panel is that life science research is evolving from a process-driven approach to a data-driven one. Here are some highlights from SLAS 2022.